Past Events

Feb 24-27, 2018 - MAQC 2018 (Shanghai, China)

The 2018 MAQC Annual Meeting, "Precision Medicine and Clinical Omics".

Click here for more information

Apr 12 2017 - MAQC Society Inaugural Meeting (Cary, NC, USA)

The first meeting organized by the MAQC Society was hosted by the SAS Institute, North Carolina, USA.

2017 theme: “Reproducible Genomics”



The First MAQC Society Annual Conference

Weida Tong, President of the Society


Reproducibility, Statistics, and the Beginning of Something Great

Russ Wolfinger, SAS Institute Inc.


The Top Five Lessons Learned from MAQC-I

Wendell Jones, PhD, Principal Bioinformaticist and Scientific Advisor EA Genomics, a business unit of Q2 Solutions


The Top Five Lessons Learned from MAQC-II

Leming Shi, PhD, Professor and Director at the Center for Pharmacogenomics and Fudan‐Zhangjiang Center for Clinical Genomics School of Life Sciences, Fudan University Shanghai, China


Top 5 Lessons‐Learned From MAQC‐III/SEQC

Weida Tong, PhD, Division of Bioinformatics and Biostatistics, NCTR/FDA


How to Achieve Reproducible Data Analysis

May Dongmei Wang, PhD


Best Practice for RNA-seq Analysis

Pawel Labaj and David Kreil, Boku University


Minimal Elements for Determination of Confidence Limits Around NGS Measurement of DNA Variant Fraction

James Willey, MD, Co‐Founder and Consultant, Accugenomics, Inc., George Isaac Chair for Cancer Research, University of Toledo Health Sciences Campus


The least common denominator: Synthetic spike‐in modules. Referencing NGS pipelines, experiments, and individual samples

Torsten Reda, PhD, CSO, Lexogen


Standards in Genomics and Epigenomics for this world and others

Christopher E. Mason, PhD, Associate Professor, Department of Physiology and Biophysics & The Institute for Computational Biomedicine (ICB), Meyer Cancer Center, Feil Family Brain and Mind Research Institute, at Weill Cornell Medicine,Fellow of the Information Society Project, Yale Law School


Towards Reproducible Cancer Genomics: Implementing Rigor And Reproducibility in Bioinformatics Group

Jian‐Liang (Jason) Li PhD, Director, Integrative Bioinformatics Group, National Institute of Environmental Health Sciences


Towards Reproducible Toxicogenomics. T test versus ANOVA

Binsheng Gong, PhD, Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration


Mechanistic approach for Enhanced Reproducibility of Genomics

Joaquín Dopazo, Clinical Bioinformatics Area, Fundación Progreso y Salud, Functional Genomics Node, (INB-ELIXIR-ES), Bioinformatics in Rare Diseases (BiER-CIBERER), Sevilla, Spain.


Advancement in Biometrology for Biomedical Science

Dr. Jing Wang, National Institute of Metrology, P.R. China


The Importance of Data and Code Sharing and Transparent Pre‐ and Post‐Publication Review. A Case Study in Pharmacogenomics

Benjamin Haibe-Kains, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Ontario Institute of Cancer Research


Genomics in vitro to in vivo Extrapolation (GIVIVE) – A Toxicogenomics Example

Zhichao Liu, PhD, DBB, NCTR, FDA